Privia Health Group Inc. (PRVA) – it’s time to buy. Check out key Indicators

Stocks of Privia Health Group Inc. (NASDAQ:PRVA) traded higher last session on Wall Street, down -1.67% to $26.46.

According to the data, Privia Health Group Inc. (NASDAQ:PRVA) has 19 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $45.00 and a low of $31.50, we find $40.00. Given the previous closing price of $26.91, this indicates a potential upside of 48.64 percent. PRVA stock price is now 1.59% away from the 50-day moving average and -0.01% away from the 200-day moving average. The market capitalization of the company currently stands at $2.97B.

A total of 0 analysts have issued a hold rating and 19 have given it a buy rating. Brokers who have rated the stock have averaged $38.58 as their price target over the next twelve months.

With the price target of $34, Evercore ISI recently initiated with Outperform rating for Privia Health Group Inc. (NASDAQ: PRVA).

In other news, Mehrotra Parth, Chief Executive Officer sold 31,744 shares of the company’s stock on Jul 31. The stock was sold for $889,784 at an average price of $28.03. Upon completion of the transaction, the Chief Executive Officer now directly owns 153,974 shares in the company, valued at $4.07 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 21, Director Sullivan William M sold 18,153 shares of the business’s stock. A total of $486,863 was realized by selling the stock at an average price of $26.82. This leaves the insider owning 5,583,096 shares of the company worth $147.73 million. Insiders disposed of 107,810,535 shares of company stock worth roughly $2.85 billion over the past 1 year. A total of 2.80% of the company’s stock is owned by insiders.

There have been several recent changes in the stakes of large investors in PRVA stock. A new stake in Privia Health Group Inc. shares was purchased by OMERS ADMINISTRATION CORP during the first quarter worth $11,057,000. ADAGE CAPITAL PARTNERS GP, L.L.C. invested $7,800,000 in shares of PRVA during the first quarter. In the first quarter, WOODLINE PARTNERS LP acquired a new stake in Privia Health Group Inc. valued at approximately $3,722,000. CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. acquired a new stake in PRVA for approximately $1,824,000. FIRST TRUST ADVISORS LP purchased a new stake in PRVA valued at around $1,799,000 in the second quarter. In total, there are 271 active investors with 86.00% ownership of the company’s stock.

Thursday’s opening bell rang with an opening price of $28.00 for Privia Health Group Inc. (NASDAQ: PRVA). During the past 12 months, Privia Health Group Inc. has had a low of $20.64 and a high of $44.64. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 1.90, and a quick ratio of 1.90. The fifty day moving average price for PRVA is $26.05 and a two-hundred day moving average price translates $26.43 for the stock.

The latest earnings results from Privia Health Group Inc. (NASDAQ: PRVA) was released for Mar, 2023. According to the Health Information Services Company, earnings per share came in at $0.06, beating analysts’ expectations of $0.02 by 0.04. This compares to -$0.17 EPS in the same period last year. The net profit margin was 1.10% and return on equity was 3.40% for PRVA. The company reported revenue of $386.28 million for the quarter, compared to $313.8 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 23.1 percent. For the current quarter, analysts expect PRVA to generate $685.98M in revenue.

Privia Health Group Inc.(PRVA) Company Profile

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers’ workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.

Related Posts